Introduction {#sec1-1}
============

Myocardial disability and tissue damage following ischemia/reperfusion (I/R) is a common disadvantage in patients with some heart diseases. I/R happens in various situations, including thrombolysis, percutaneous coronary angioplasty, organ transplantation, and coronary bypass. I/R injury describes the additional damage occurs by reperfusion in tissues endured ischemia.\[[@ref1]\] In the process of reperfusion, tissue cells produce excessive reactive oxygen species (ROS), and hence oxidative stress is an important way involved in I/R injury. Studies have shown that increased expression of antioxidant enzymes will protect against postischemic injury which can lead to apoptosis.\[[@ref2]\] Former reports revealed that antioxidant therapy after I/R could improve myocardium after ROS-induced damage.\[[@ref3][@ref4]\] Antioxidant enzymes such as superoxide dismutase and catalase (CAT) are capable to protect cardiac tissue against the detrimental effects of ROS.\[[@ref5][@ref6]\] Previously, it is shown that ROS scavenger antioxidants could act as a treatment for I/R-mediated cardiac injury. Thus, it is necessary to find out and identify suitable antioxidant interventions to rectify myocardial tissue damage and dysfunction induced by I/R.\[[@ref7]\] The presence antioxidant agents in the plants species or in natural resources have been previously highlighted by many studies.\[[@ref8][@ref9][@ref10]\] The medicinal use of plants dates back to ancient times. *Teucrium polium* L. (*Lamiaceae*) is a perennial shrub, 20--50 cm high, distributed widely in the dry and stony places of the hills and deserts of almost all Mediterranean countries, South Western Asia, Europe and North Africa. Sessile, oblong or linear leaves have a length of about 3 cm. *T. polium* that locally called kalpooreh is widely found in Iran has small cluster of pink to white flowers with an aromatic odor originated from its bruised foliage.\[[@ref11]\] Phytochemical investigations have shown that *T. polium* contains various compounds such as terpenoids, flavonoids, and iridoids.\[[@ref12]\] *T. polium* is a plant that has been used for over 2000 years in traditional medicine due to its diuretic, diaphoretic, tonic, antipyretic, antispasmodic, and cholagogic properties.\[[@ref13][@ref14]\] In addition, the plant possesses hypoglycemic, insulinotropic, and anti-inflammatory activities\[[@ref15]\] and has antinociceptive and antioxidant properties.\[[@ref16][@ref17][@ref18]\] There is increasing evidence of cardiovascular effects of *T. polium* such as positive inotropic and chronotropic,\[[@ref19]\] reducing of blood pressure,\[[@ref20][@ref21]\] and lowering blood lipid.\[[@ref22]\] Thus, regarding to above-mentioned properties of this plant, we decided to evaluate the effects of *T. polium* on cardiac functional parameters and oxidative stress injury in a model of I/R injury in the isolated rat heart.

Materials and Methods {#sec1-2}
=====================

Plant material and preparation of the extract {#sec2-1}
---------------------------------------------

The aerial part of *T. polium* was collected in autumn from the Khorasan Province, Ferdows, Iran, and identified in the Ferdowsi University Herbarium (voucher No. 152-2016-4) and then dried at room temperature. The aerial parts (300 g) of the plant were soaked in ethanol (50%) for 48 h and filter paper was used to filter the solute after mixing. The solution was then dried using a 40°C oven for 72 h. The dried extract was dissolved in the distilled water to make different concentrations of 0.5, 1, and 2 mg/ml.\[[@ref21][@ref23]\]

Animals and experimental design {#sec2-2}
-------------------------------

In this study, fifty male Wistar rats weighing 250--280 g (obtained from animal house of Mashhad University of Medical Sciences \[MUMS\]) were divided into five groups, *n* = 10 for each. The following groups were involved in the study; groups of Control, Control-ischemia (CI), Ext 0.5, Ext 1 and Ext 2.

Animals were maintained under 12 h light and 12 h of darkness, unrestricted access to food and water at 22 ± 4°C. All experiments were conducted in accordance with the Animal Experimentation Ethics Committee of MUMS (approval no. 910762). The animals were heparinized (375 units/200 g) and anesthetized by intraperitoneal injection of ketamine (60 mg/kg), after tracheotomy and opening the chest, the hearts were excised quickly and cooled in ice-cold saline until contractions stopped. Hearts were then mounted on a Langendorff apparatus and perfused isovolumically at a constant pressure of 70 mmHg with Krebs--Henseleit bicarbonate (K-H) buffer of the following composition (in mmol/L): NaCl, 120; HNaCO~3~, 25; KCl, 4.8; MgSO~4~, 1.33; KH~2~ PO~4~, 1.2; CaCl~2~, 1.6; Na~2~ EDTA, 0.02; and glucose, 10. The perfusate was gassed with 95% O~2~ and 5% CO~2~(pH 7.4) and kept at a constant temperature of 37°C. Hearts in control group were uninterruptedly perfused with K-H buffer purely for the 80 min. CI group hearts were perfused first for 20 min, and then we suspended the infusion for 20 min and reperfusion for 40 min. Hearts in pretreated groups were perfused first for 20 min instead of K-H buffer with different concentrations of *T. polium* extract (0.5, 1 and 2 mg/ml) and then, we suspended the infusion for 20 min, and reperfusion was continued for 40 min with K-H buffer.\[[@ref24]\]

Measurement of heart cardiodynamic parameters {#sec2-3}
---------------------------------------------

For measurement of left ventricular pressures (LVPs), the left atrium was exposed, and a latex balloon connected to pressure transducer was inserted into the left ventricle through the mitral valve. The volume of the balloon was adjusted to obtain left ventricular end-diastolic pressure of 10 mmHg. The indices of myocardial function were the left ventricular developed pressure (LVDP), which was defined as peak systolic pressure minus end diastolic pressure, heart rate (HR; cardiac spontaneous rhythm was counted per min), peak rate of contraction (*+dp/dt*~max~), peak rate of relaxation (*−dp/dt*~min~), and the rate pressure product (RPP = LVDP × HR) which were obtained using a digital data acquisition system (AD Instrument, Australia).\[[@ref25]\] Coronary flow (CF) was measured by timed collections of the coronary effluent during all phases of the experiment.

Enzymes activities assays {#sec2-4}
-------------------------

To determine lactate dehydrogenase (LDH) and creatine kinase (CK) activity, as myocardial damage markers in the perfusate, samples were collected from the coronary effluent before 2 min of ischemia and during the first 8 min of reperfusion. LDH and CK were assayed spectrophotometrically using commercial kits (Pars Azmoon, Iran).

Assay of oxidative stress {#sec2-5}
-------------------------

When the perfusions finished, the hearts were frozen under the condition of −70°C to prepare for further testing. The frozen hearts were crushed to powder by liquid nitrogen-chilled tissue pulverizer. For tissue analyses, weighed amounts of the frozen tissues were homogenized in appropriate buffer using microcentrifuge tube homogenizer.

Assessment of lipid peroxidation {#sec2-6}
--------------------------------

Malondialdehyde (MDA) level is an index of lipid peroxidation. MDA reacts with thiobarbituric acid (TBA) as a TBA-reactive substance (TBARS) and produces a red complex. Briefly, 1 mL of homogenates was added to 2 mL of a complex solution containing TBA/trichloroacetic acid/hydrochloric acid, and it was then boiled in a water bath for 40 min. After reaching to the room temperature, the solution was centrifuged at 1000 g for 10 min. The absorbance was read at 535 nm\[[@ref26]\] and was expressed as TBARS in nmol/g tissue weight, using an extinction coefficient of 1.56 × 10^5^ cm^−1^/M^−1^.

Determination of thiol concentration {#sec2-7}
------------------------------------

2, 2'-dinitro-5, 5'-dithiodibenzoic acid (DTNB) reagent, which reacts with the SH group, was used to determine the total thiol groups. The produced yellow complex has a peak absorbance at 412 nm. Briefly, 50 μL of tissue homogenates was added to 1 ml tris-ethylenediaminetetraacetic acid (EDTA) buffer (pH = 8.6), and the absorbance was read at 412 nm against tris-EDTA buffer alone (A1). Then, 20 μL of 10 mM solution of DTNB was mixed with the solution, and it was stored in room temperature for 15 min, and the absorbance was read again (A2). The absorbance of DTNB reagent was also read as blank (B).\[[@ref27]\] The thiol levels were determined by a spectrophotometric method based on the use of Ellman\'s reagent (DTNB solution), and the results were expressed per gram of tissue.

Total thiol concentration (mM) = (A2 − A1 − B) ×1.07 (/0.05 × 14.150).

Determination of superoxide dismutase activity {#sec2-8}
----------------------------------------------

Superoxide dismutase (SOD) activity was measured by the procedure of Madesh and Balasubramanian. A colorimetric assay involving generation of superoxide by pyrogallol autooxidation and the inhibition of superoxide-dependent reduction of the tetrazolium dye, 3-(4,5-dimethylthiazol-2-yl) 2, 5-diphenyltetrazolium bromide (MTT) to its Formosan by the SOD was measured at 570 nm. One unit of SOD activity was defined as the amount of enzyme causing 50% inhibition in the MTT reduction rate.\[[@ref28]\]

Determination of catalase activity {#sec2-9}
----------------------------------

CAT activity was determined by the method of Aebi with hydrogen peroxide (30 mM) as the substrate.\[[@ref29]\] By measuring the decrease in absorbance at 240 nm/min, the rate constant of the enzyme was determined (EC 1.11.1.16). One unit of CAT activity is determined as the micromoles of the hydrogen peroxide consumed per 100 g sample. One unit (U) is defined as the amount of enzyme which decomposes 1 mol of H~2~O~2~ per min at 25°C and pH 7.0.

Analysis of results and statistical analysis {#sec2-10}
--------------------------------------------

Data were expressed as mean ± standard error mean. Comparisons between groups in cardiodynamic and cardiac enzyme values were made using repeated measures ANOVA (with Tukey--Kramer multiple posttest for the most effective dose). In biochemical assays, comparison between groups was performed using ANOVA with Tukey--Kramer multiple posttest. Significance was set at *P* \< 0.05. All statistical analyses were made using GraphPad Instat version 3.00 (GraphPad Software, San Diego, CA, USA).

Results {#sec1-3}
=======

Since the changes in all cardiac parameters were almost similar in all of the time duration before ischemia and as well as those of after reperfusion, we mentioned only the average changes of 2 min before ischemia and the first 10 min of reperfusion period.

The effects of *Teucrium polium* on cardiac function and coronary flow {#sec2-11}
----------------------------------------------------------------------

Two minutes after the reperfusion, HR in all of the extract groups showed a significant increase compared to the CI group (*P* \< 0.01 to *P* \< 0.001), as well as this increasing trend continued by the end of the reperfusion period \[[Figure 1](#F1){ref-type="fig"}\].

![Time course of change in heart rate, left ventricular developed pressure and rate pressure product in control ischemia and different concentrations of *Teucrium polium* extract (0.5, 1 and 2 mg/ml; Ext 0.5, Ext 1, Ext 2) pretreated rat groups during ischemia--reperfusion. The data provided are mean ± standard error mean. For repeated measures ANOVA; \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001, ^+^*P* \< 0.05 and ^+++^*P* \< 0.001, ^\$\$^*P* \< 0.01, for Tukey--Kramer multiple posttests; ^¶^*P* \< 0.05, ^¶¶^*P* \< 0.01 and ^¶¶¶^*P* \< 0.001, all compared to control ischemia group](ABR-7-15-g001){#F1}

In the first 10 min after the establishment of reperfusion, LVDP in Ext 0.5 group and RPP in both groups of Ext 0.5 and Ext 1 increased compared to the CI group (*P* \< 0.05 to *P* \< 0.01) \[[Figure 1](#F1){ref-type="fig"}\].

\+*dp/dt*~max~ also showed increasing trend during the first 10 min of reperfusion in a group of Ext 0.5 compared to CI group (*P* \< 0.05). On the other hand, −*dp/dt*~min~ in all groups of extract decreased compared to the CI group (*P* \< 0.05 to *P* \< 0.01) \[[Figure 2](#F2){ref-type="fig"}\].

![Time course of change in the rate of ventricular pressure development (+dp/dt) and the rate of ventricular pressure decline (−dp/dt) in control ischemia and different concentrations of *Teucrium polium* extract (0.5, 1, and 2 mg/ml; Ext 0.5, Ext 1, Ext 2) pretreated rat groups during ischemia--reperfusion. The data provided are mean ± standard error mean. For repeated measures ANOVA; \**P* \< 0.05 and \*\**P* \< 0.01, ^+^*P* \< 0.05, ^\$^*P* \< 0. 05, for Tukey--Kramer multiple posttests; ^¶^*P* \< 0.05, all compared to control ischemia group](ABR-7-15-g002){#F2}

CF in all three groups of the extract increased compared to the CI group during the first 10 min of reperfusion, however, this increase was significant only in the group of Ex 0.5 (*P* \< 0.05) \[[Figure 3](#F3){ref-type="fig"}\].

![Time course of change in rate of coronary flow, outflow of lactate dehydrogenase and creatine kinase enzymes in control ischemia and different concentrations of *Teucrium polium* extract (0.5, 1 and 2 mg/ml; Ext 0.5, Ext 1, Ext 2) pretreated rat groups during ischemia--reperfusion. The data provided are mean ± standard error mean. For repeated measures ANOVA; \**P* \< 0.05 and \*\**P* \< 0.01, for Tukey--Kramer multiple posttests; ^¶^*P* \< 0.05 and ^¶¶^*P* \< 0.01, all compared to control ischemia group](ABR-7-15-g003){#F3}

The effects of *Teucrium polium* on cardiac lactate dehydrogenase and creatine kinase release {#sec2-12}
---------------------------------------------------------------------------------------------

The extent of reperfusion injury in all groups of hearts was determined from the release of a marker intracellular enzyme into the effluent. As shown in [Figure 3](#F3){ref-type="fig"}, after 20 min of ischemia, in the first moments, the leakage of LDH and CK markedly increased in CI group compared to other pretreated groups. The *T. polium* pretreatment by dose of 0.5 mg/ml significantly reduced the I/R-induced increase in LDH and CK release in rat heart (*P* \< 0.05 to *P* \< 0.01) \[[Figure 3](#F3){ref-type="fig"}\].

The effects of *Teucrium polium* on oxidative stress state induced by ischemia--reperfusion Injury {#sec2-13}
--------------------------------------------------------------------------------------------------

To identify the possible mechanisms of *T. polium* on cardioprotection, the TBARS and thiol levels as well as SOD and CAT activities were determined in myocardial tissue. As shown in [Figure 4](#F4){ref-type="fig"}, the TBARS level was significantly decreased in all groups of extract compared to CI group (*P* \< 0.05 to *P* \< 0.01) and the total thiol concentration that had been decreased in CI group showed significant increase in all groups of extract compared to CI group (*P* \< 0.05 to *P* \< 0.01).

![The level of formation of thiobarbituric acid reactive substances, expressed as nmol malondialdehyde/g heart weight and total thiol concentration in the heart tissues of control, control ischemia and different concentrations of *Teucrium polium* extract (0.5, 1 and 2 mg/ml; Ext 0.5, Ext 1, Ext 2) pretreated rat groups during ischemia--reperfusion. The data provided are mean ± standard error mean ^++^*P* \< 0.01 and ^+++^*P* \< 0.001 compared to control group, ^¶^*P* \< 0.05 and ^¶¶^*P* \< 0.01 compared to control ischemia group](ABR-7-15-g004){#F4}

The SOD activity significantly increased in EX 0.5 group after reperfusion compared to CI group (*P* \< 0.05) and CAT activity showed augmentation in extract pretreated groups (*P* \< 0.01 to *P* \< 0.001), whereas these values showed significant reductions in CI group compared to control group (*P* \< 0.01 to *P* \< 0.001) \[[Figure 5](#F5){ref-type="fig"}\]. The effects of the two higher concentrations of *T. polium* on oxidative stress parameters were lower than the effect of its low concentration (*P* \< 0.05 to *P* \< 0.001).

![Superoxide dismutase and catalase enzyme activity values in the heart tissues of control, control ischemia and different concentrations of *Teucrium polium* extract (0.5, 1 and 2 mg/ml; Ext 0.5, Ext 1, Ext 2) pretreated rat groups during ischemia--reperfusion. The data provided are mean ± standard error mean ^++^*P* \< 0.01 and ^+++^*P* \< 0.001 compared to control group, ^¶^*P* \< 0.05, ^¶¶^*P* \< 0.01 and ^¶¶¶^*P* \< 0.001 compared to control ischemia group](ABR-7-15-g005){#F5}

Discussion {#sec1-4}
==========

It has been a general consensus about the role of oxidative stress, which is associated with increased formation of ROS, in the pathogenesis of I/R injury.\[[@ref30]\] A clinical consequence after therapeutic procedures such as thrombolysis, angioplasty, and coronary bypass surgery could be I/R-induced myocardial damages. These impairments include cardiac contractile dysfunction, arrhythmias as well as irreversible myocyte damage. The imbalance between the formation of oxidants and the availability of endogenous antioxidants in the heart is thought to be one of the reasons for these shortcomings.\[[@ref31]\] In the present study, this imbalance was obvious after ischemia, administration of hydroalcoholic extract of *T. polium* caused significant augmentation of endogenous myocardial antioxidants (SOD, CAT, thiol) and reduced basal lipid peroxidation (TBARS) after reperfusion of ischemic hearts.

The recovery of cardiac function and myocardial enzyme release has been considered as our goals to evaluate the effects of *T. polium* on I/R injury. Pretreatment with *T. polium* however resulted in decreased I/R injury and excess ROS generation; this led to an improved cardiac function. In our work, this was reflected by the reducing necrotic damage (LDH and CK release). In the absence of this protection, additional cell damages including necrosis and apoptosis which lead to more release of myocardiac enzymes will be predictable. Cardiodynamic parameters, including HR, alongside with CF measurement are considered as improvement factors of left ventricular function in isolated rat hearts.\[[@ref24]\] From this study, HR, LVDP, RPP, the recovery rate of ± *dp/dt*~max~ and CF values during the reperfusion period were increased significantly by *T. polium* pretreatment. These data suggested that *T. polium* could ameliorate cardiac function after I/R injury.

There is a wide range of studies on the antioxidant and free radical scavenging properties of *T. polium* using *in vitro* and *in vivo* models.\[[@ref11]\] Regarding the highest total flavonoids (0.20% of air-dried aerial parts) content in the *T. polium* extract, investigators concluded that the antioxidant effects of the plant could be due to the flavonoids, but could also be a result of the activity of other secondary biomolecules present in the extract.\[[@ref24]\] Flavonoids are known as a good protector of myocardial tissue against I/R injury due to their diverse properties, such as anti-inflammatory, antioxidant, vasodilatory, and antiplatelet aggregation.\[[@ref32]\] On the other hand, previous studies have been shown *T. polium* has inotropic and chronotropic effects\[[@ref19][@ref23]\] so improvement of cardiodynamic parameters in pretreated groups after reperfusion could be attributed to these properties of plant.

Hypotensive\[[@ref21]\] and vasodilatory effects of *T. polium* has been observed previously in our lab (some parts of data not published), thus the augmentation of CF in extract pretreated groups could be due to this vasorelaxation which was mainly mediated by inhibition of calcium influx in vascular smooth muscle cells, moreover, vasodilation in lower concentrations mediated by nitric oxide and prostacyclin. Although considering to the good effects of *T. polium* on LVDP in this study, it seems the reduction of diastolic LVP ameliorates CF.

Our data demonstrated that the lower concentration of extract had more effectivity on cardiodynamics and oxidative balance, former studies showed cytotoxicity of *T. polium* in different types of cell lines,\[[@ref33][@ref34]\] and also hepatotoxicity of this plant was reported by some investigators.\[[@ref35][@ref36]\] On the other hand, since our results rely on *in vitro* data and regarding to the toxicity of *T. polium*, to better evaluation the efficiency of this plant, it is recommended much lower doses of its extract considered in further studies.

Conclusions {#sec1-5}
===========

This study demonstrated a cardioprotective effect of *T. polium* on isolated heart against oxidative stress during ischemia reperfusion injury; however, further studies are needed to determine the related signaling pathways of specific *T. polium* compounds and/or their respective metabolites as well as to confirm that *T. polium* could be a potentially therapeutic substance.
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